For in vitro diagnostic use. Others Elecsys HIV combi PT IVD Elecsys® HIV combi PT CPS_000863 HIV-1 antigen and total antibodies to HIV-1 and HIV-2 08924180160 HIV combi PT Elecsys cobas e 200 V2 Elecsys HIV combi PT 07613336170212 Reagents, kits 200 tests cobas e 602 true 08924163190 HIV combi PT Elecsys cobas e 100 V2 Elecsys HIV combi PT 07613336170175 Reagents, kits 100 tests cobas e 602 true 08924180190 HIV combi PT Elecsys cobas e 200 V2 Elecsys HIV combi PT 07613336170205 Reagents, kits 200 tests cobas e 411/601/602 true 07914504190 HIV combi PT Elecsys cobas e 200 Elecsys HIV combi PT 07613336148396 Reagents, kits 200 tests cobas e 411/601/602 true 08924163160 HIV combi PT Elecsys cobas e 100 V2 Elecsys HIV combi PT 07613336170182 Reagents, kits 100 tests cobas e 602 true 05390095160 HIV combi PT Elecsys cobas e 100 Elecsys HIV combi PT 04015630942497 Reagents, kits 100 tests cobas e 601/602 true 05390095190 HIV combi PT Elecsys cobas e 100 Elecsys HIV combi PT 04015630926633 Reagents, kits 100 tests cobas e 411/601/602 true 08924180501 Elecsys HIV combi PT en 3 FF00000006BE650E FF00000004BCC40E 08924180160 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys HIV combi PT is an immunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1 (HIV‑1 groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV combi PT is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women.The Elecsys HIV combi PT assay is not intended for the screening of blood or plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 602 immunoassay analyzer.A reactive result using the Elecsys HIV combi PT assay does not distinguish HIV‑1 p24 antigen, HIV‑1 antibody, HIV‑2 antibody, and HIV‑1 group O antibody. The PreciControl HIV Gen II and the PreciControl HIV; HIV‑2+GrpO are intended to be used for quality control of the Elecsys HIV combi PT immunoassay on the cobas e 602 immunoassay analyzer. en 08924163500 Elecsys HIV combi PT en 2 FF0000000627DA0E FF00000003FC0B0E 08924163190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08924163501 Elecsys HIV combi PT en 1 FF00000004BCC00E FF00000004BCC00E 08924163160 08924163190 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys HIV combi PT is an immunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1 (HIV‑1 groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV combi PT is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women.The Elecsys HIV combi PT assay is not intended for the screening of blood or plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 602 immunoassay analyzer.A reactive result using the Elecsys HIV combi PT assay does not distinguish HIV‑1 p24 antigen, HIV‑1 antibody, HIV‑2 antibody, and HIV‑1 group O antibody. The PreciControl HIV Gen II and the PreciControl HIV; HIV‑2+GrpO are intended to be used for quality control of the Elecsys HIV combi PT immunoassay on the cobas e 602 immunoassay analyzer. en 08924180500 Elecsys HIV combi PT en 2 FF000000062C820E FF00000003FC560E 08924180190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07914504500 Elecsys HIV combi PT en 5 FF000000062ED10E FF00000001D8F30E 07914504190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 05390095501 Elecsys HIV combi PT HIV-1 antigen and total antibodies to HIV-1 and HIV-2 en 3 FF00000003B6180E FF000000020E280E 05390095160 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys HIV combi PT is an immunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1 (HIV‑1 groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV combi PT is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women.The Elecsys HIV combi PT assay is not intended for the screening of blood or plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 602 immunoassay analyzer.A reactive result using the Elecsys HIV combi PT assay does not distinguish HIV‑1 p24 antigen, HIV‑1 antibody, HIV‑2 antibody, and HIV‑1 group O antibody. The PreciControl HIV Gen II and the PreciControl HIV; HIV‑2+GrpO are intended to be used for quality control of the Elecsys HIV combi PT immunoassay on the cobas e 602 immunoassay analyzer. en 05390095500 Elecsys HIV combi PT en 12 FF000000062E1E0E FF000000001EEC0E 05390095190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en